Divya J Karsanji1, Neesh Pannu2, Braden J Manns1,3,4,5, Brenda R Hemmelgarn1,3,4,5, Zhi Tan1, Kailash Jindal2, Nairne Scott-Douglas1,5, Matthew T James6,3,4,5. 1. Division of Nephrology, Department of Medicine. 2. Division of Nephrology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. 3. Department of Community Health Sciences. 4. O'Brien Institute for Public Health, and. 5. Libin Cardiovascular Institute of Alberta, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; and. 6. Division of Nephrology, Department of Medicine, mjames@ucalgary.ca.
Abstract
BACKGROUND AND OBJECTIVES: Recent guidelines suggest that patients should be evaluated after AKI for resolution versus progression of CKD. There is uncertainty as to the role of nephrologists in this process. The objective of this study was to compare the follow-up recommendations from nephrologists with contemporary processes of care for varying scenarios of patients hospitalized with AKI. DESIGN, SETTING PARTICIPANTS, & MEASUREMENTS: We surveyed Canadian nephrologists using a series of clinical vignettes of patients hospitalized with severe AKI and asked them to rank their likelihood of recommending follow-up for each patient after hospital discharge. We compared these responses with administrative health data on rates of community follow-up with nephrologists for patients hospitalized with AKI in Alberta, Canada between 2005 and 2014. RESULTS: One hundred forty-five nephrologists participated in the survey (46% of the physician membership of the Canadian Society of Nephrology). Nephrologists surveyed indicated that they would definitely or probably re-evaluate patients in 87% of the scenarios provided, with a higher likelihood of follow-up for patients with a history of preexisting CKD (89%), heart failure (92%), receipt of acute dialysis (91%), and less complete recovery of kidney function (98%). In contrast, only 24% of patients with similar characteristics were seen by a nephrologist in Alberta within 1 year after a hospitalization with AKI, with a trend toward lower rates of follow-up over more recent years of the study. Follow-up with a nephrologist was significantly less common among patients over the age of 80 years old (20%) and more common among patients with preexisting CKD (43%) or a nephrology consultation before or during AKI hospitalization (78% and 41%, respectively). CONCLUSIONS: There is a substantial disparity between the opinions of nephrologists and actual processes of care for nephrology evaluation of patients after hospitalization with severe AKI.
BACKGROUND AND OBJECTIVES: Recent guidelines suggest that patients should be evaluated after AKI for resolution versus progression of CKD. There is uncertainty as to the role of nephrologists in this process. The objective of this study was to compare the follow-up recommendations from nephrologists with contemporary processes of care for varying scenarios of patients hospitalized with AKI. DESIGN, SETTING PARTICIPANTS, & MEASUREMENTS: We surveyed Canadian nephrologists using a series of clinical vignettes of patients hospitalized with severe AKI and asked them to rank their likelihood of recommending follow-up for each patient after hospital discharge. We compared these responses with administrative health data on rates of community follow-up with nephrologists for patients hospitalized with AKI in Alberta, Canada between 2005 and 2014. RESULTS: One hundred forty-five nephrologists participated in the survey (46% of the physician membership of the Canadian Society of Nephrology). Nephrologists surveyed indicated that they would definitely or probably re-evaluate patients in 87% of the scenarios provided, with a higher likelihood of follow-up for patients with a history of preexisting CKD (89%), heart failure (92%), receipt of acute dialysis (91%), and less complete recovery of kidney function (98%). In contrast, only 24% of patients with similar characteristics were seen by a nephrologist in Alberta within 1 year after a hospitalization with AKI, with a trend toward lower rates of follow-up over more recent years of the study. Follow-up with a nephrologist was significantly less common among patients over the age of 80 years old (20%) and more common among patients with preexisting CKD (43%) or a nephrology consultation before or during AKI hospitalization (78% and 41%, respectively). CONCLUSIONS: There is a substantial disparity between the opinions of nephrologists and actual processes of care for nephrology evaluation of patients after hospitalization with severe AKI.
Authors: Edward D Siew; Josh F Peterson; Svetlana K Eden; Adriana M Hung; Theodore Speroff; T Alp Ikizler; Michael E Matheny Journal: J Am Soc Nephrol Date: 2011-12-08 Impact factor: 10.121
Authors: Sushrut S Waikar; Ron Wald; Glenn M Chertow; Gary C Curhan; Wolfgang C Winkelmayer; Orfeas Liangos; Marie-Anne Sosa; Bertrand L Jaber Journal: J Am Soc Nephrol Date: 2006-04-26 Impact factor: 10.121
Authors: Ron Wald; Robert R Quinn; Neill K Adhikari; Karen E Burns; Jan O Friedrich; Amit X Garg; Ziv Harel; Michelle A Hladunewich; Jin Luo; Muhammad Mamdani; Jeffrey Perl; Joel G Ray Journal: Am J Med Date: 2012-04-18 Impact factor: 4.965
Authors: Ziv Harel; Ron Wald; Joanne M Bargman; Muhammad Mamdani; Edward Etchells; Amit X Garg; Joel G Ray; Jin Luo; Ping Li; Robert R Quinn; Alan Forster; Jeff Perl; Chaim M Bell Journal: Kidney Int Date: 2013-01-16 Impact factor: 10.612
Authors: Gulshan Sharma; Kathlyn E Fletcher; Dong Zhang; Yong-Fang Kuo; Jean L Freeman; James S Goodwin Journal: JAMA Date: 2009-04-22 Impact factor: 56.272
Authors: Jay L Xue; Frank Daniels; Robert A Star; Paul L Kimmel; Paul W Eggers; Bruce A Molitoris; Jonathan Himmelfarb; Allan J Collins Journal: J Am Soc Nephrol Date: 2006-02-22 Impact factor: 10.121
Authors: Chi-Yuan Hsu; Vernon M Chinchilli; Steven Coca; Prasad Devarajan; Nasrollah Ghahramani; Alan S Go; Raymond K Hsu; T Alp Ikizler; James Kaufman; Kathleen D Liu; Chirag R Parikh; W Brian Reeves; Mark Wurfel; Michael Zappitelli; Paul L Kimmel; Edward D Siew Journal: JAMA Intern Med Date: 2020-03-01 Impact factor: 21.873
Authors: Edward D Siew; Sharidan K Parr; Marcus G Wild; Swee-Ling Levea; Kermaan G Mehta; Ebele M Umeukeje; Samuel A Silver; T Alp Ikizler; Kerri L Cavanaugh Journal: Am J Nephrol Date: 2019-04-17 Impact factor: 3.754
Authors: Gurmukteshwar Singh; Yirui Hu; Steven Jacobs; Jason Brown; Jason George; Maria Bermudez; Kevin Ho; Jamie A Green; H Lester Kirchner; Alex R Chang Journal: Kidney360 Date: 2021-07-13
Authors: Sunchit Madan; Patrick A Norman; Ron Wald; Javier A Neyra; Alejandro Meraz-Muñoz; Ziv Harel; Samuel A Silver Journal: Can J Kidney Health Dis Date: 2022-06-14
Authors: Erin F Barreto; Diana J Schreier; Heather P May; Kristin C Mara; Alanna M Chamberlain; Kianoush B Kashani; Shannon L Piche; Chung-Il Wi; Sandra L Kane-Gill; Victoria T Smith; Andrew D Rule Journal: Am J Nephrol Date: 2021-11-02 Impact factor: 3.754
Authors: Kianoush Kashani; Mitchell Howard Rosner; Michael Haase; Andrew J P Lewington; Donal J O'Donoghue; F Perry Wilson; Mitra K Nadim; Samuel A Silver; Alexander Zarbock; Marlies Ostermann; Ravindra L Mehta; Sandra L Kane-Gill; Xiaoqiang Ding; Peter Pickkers; Azra Bihorac; Edward D Siew; Erin F Barreto; Etienne Macedo; John A Kellum; Paul M Palevsky; Ashita Jiwat Tolwani; Claudio Ronco; Luis A Juncos; Oleksa G Rewa; Sean M Bagshaw; Theresa Ann Mottes; Jay L Koyner; Kathleen D Liu; Lui G Forni; Michael Heung; Vin-Cent Wu Journal: Clin J Am Soc Nephrol Date: 2019-05-17 Impact factor: 8.237